Treatment strategy for incidental gallbladder cancer

doi:10.16139/j.1007-9610.2019.02.008

[1] Sharma A, Sharma KL, Gupta A, et al.Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update[J]. World J Gastroenterol,2017,23(22):3978-3998.
[2] 张明迪, 龚伟, 郑莹, 等. 上海市胆囊癌流行状况和趋势分析[J]. 中国实用外科杂志,2013,33(8):691-694.
[3] 邹珍, 鲍萍萍, 吴春晓, 等. 上海市人群2004—2008年胆囊癌生存率分析[J]. 上海预防医学,2018,30(7):569-573,583.
[4] Butte JM, Gonen M, Allen PJ, et al.The role of laparoscopic staging in patients with incidental gallbladder cancer[J]. HPB (Oxford),2011,13(7):463-472.
[5] Bridgewater JA, Goodman KA, Kalyan A, et al.Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling[J]. Am Soc Clin Oncol Educ Book,2016,35:e194-e203.
[6] 安宏建, 朱金荣, 包焰峰. 腹腔镜与开腹手术相关意外胆囊癌临床对比分析[J]. 中国现代手术学杂志,2015, 19(5):343-346.
[7] 刘恩菊, 高玉堂, 邓杰, 等. 既往疾病史和胆道癌关系的全人群病例对照研究[J]. 肿瘤,2002,22(6):453-456.
[8] Benson AR 3rd, D'Angelica MI, Abbott DE, et al. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017[J]. J Natl Compr Canc Netw,2017,15(5):563-573.
[9] Lee H, Kwon W, Han Y, et al.Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis[J]. J Hepatobiliary Pancreat Sci,2018,25(2):131-141.
[10] Jang JY, Heo JS, Han Y, et al.Impact of type of surgery on survival outcome in patients with early gallbladder cancer in the era of minimally invasive surgery: oncologic safety of laparoscopic surgery[J]. Medicine (Baltimore),2016,95(22):e3675.
[11] Kim HS, Park JW, Kim H, et al.Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study[J]. J Hepatobiliary Pancreat Sci,2018,25(12):533-543.
[12] Goetze TO, Paolucci V. Immediate radical re-resection of incidental T1b gallbladder cancer and the problem of an adequate extent of resection (results of the German Re-gistry “Incidental Gallbladder Cancer”)[J]. Zentralbl Chir,2014,139 Suppl 2:e43-e48.
[13] Lee SE, Kim SW, Han HS, et al.Surgical strategy for T2 gallbladder cancer: nationwide multicenter survey in Korea[J]. J Korean Med Sci,2018,33(28):e186.
[14] D'Hondt M, Lapointe R, Benamira Z, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre expe-rience[J]. Eur J Surg Oncol,2013,39(6):548-553.
[15] Hickman L, Contreras C.Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies[J]. Surg Clin North Am,2019,99(2):337-355.
[16] Ethun CG, Postlewait LM, Le N, et al.Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. JAMA Surg,2017,152(2):143-149.
[17] Rathanaswamy S, Misra S, Kumar V, et al.Incidentally detected gallbladder cancer- the controversies and algorithmic approach to management[J]. Indian J Surg,2012, 74(3):248-254.
[18] de Aretxabala X, Oppliger F, Solano N, et al. Laparoscopic management of incidental gallbladder cancer[J]. Surg Endosc,2018,32(10):4251-4255.
[19] Hundal R, Shaffer EA.Gallbladder cancer: epidemiology and outcome[J]. Clin Epidemiol,2014,6:99-109.
[20] Lee HY, Kim YH, Jung GJ, et al.Prognostic factors for gallbladder cancer in the laparoscopy era[J]. J Korean Surg Soc,2012,83(4):227-236.
[21] Ethun CG, Postlewait LM, Le N, et al.Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. J Surg Oncol,2017,115(7):805-811.
[22] Tsujita E, Ikeda Y, Kinjo N, et al.Late-type port-site recurrence of unexpected gallbladder carcinoma 11 years after laparoscopic cholecystectomy[J]. Asian J Endosc Surg,2014,7(4):304-307.
[23] 李斌, 刘辰, 姜小清. 胆囊癌规范化诊治专家共识(2016)[J]. 临床肝胆病杂志,2017,33(4):611-620.
[24] Goetze TO, Paolucci V.The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry[J]. Surg Endosc,2012,26(5):1382-1389.
[25] Kishi Y, Nara S, Esaki M, et al.Extent of lymph node dissection in patients with gallbladder cancer[J]. Br J Surg,2018,105(12):1658-1664.
[26] Vega EA, Vinuela E, Yamashita S, et al.Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status[J]. J Gastrointest Surg,2018,22(1):43-51.
[27] Shimizu H, Kimura F, Yoshidome H, et al.Aggressive surgical approach for stage Ⅳ gallbladder carcinoma based on Japanese Society of Biliary Surgery classification[J]. J Hepatobiliary Pancreat Surg,2007,14(4):358-365.
[28] Nigri G, Berardi G, Mattana C, et al.Routine extra-he-patic bile duct resection in gallbladder cancer patients without bile duct infiltration: A systematic review[J]. Surgeon,2016,14(6):337-344.
[29] Gani F, Buettner S, Margonis GA, et al.Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer[J]. J Surg Oncol,2016, 114(2):176-180.
[30] Kurahara H, Maemura K, Mataki Y, et al.Indication of extrahepatic bile duct resection for gallbladder cancer[J]. Langenbecks Arch Surg,2018,403(1):45-51.
[31] NCCN. The NCCN clinical practice guidelines in oncology: hepatobiliary cancers (version 1.2019) [EB/OL]. Fort Washington: NCCN, 2019 [2018-12-17]. https://www.nccn.org/professionals/physician_gls/default.aspx
[32] Ostwal V, Swami R, Patkar S, et al.Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage Ⅱ and stage Ⅲ gallbladder cancers (GBC): a potential way forward[J]. Med Oncol,2018,35(4):57.
[33] Keane FK, Zhu AX, Hong TS.Radiotherapy for biliary tract cancers[J]. Semin Radiat Oncol,2018,28(4):342-350.
[34] You MS, Ryu JK, Choi YH, et al.Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin[J]. BMC Cancer,2019,19(1):10.
[35] Arkenau H T, Martin-Liberal J, Calvo E, et al.Ramucirumab plus Pembrolizumab in patients with previously treated advanced or metastatic biliary tract cancer: nonrandomized, open-label, phase Ⅰ trial (JVDF)[J]. Onco-logist,2018,23(12):1136-1407.

Treatment strategy for incidental gallbladder cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHANG Hongzhan, ZHANG Kai. Current status and prospect of endoscopic photodynamic therapy for unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 316-320.
[2]	ZHU Siwei, YIN Xinmin. Laparoscopic radical resection of hilar cholangiocarcinoma: current status and considerations [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 100-103.
[3]	LI Xiangcheng, CHEN Yananlan, LI Changxian. Vascular reconstruction in radical resection for hilar cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 104-109.
[4]	XING Ying, CHENG Shi. Neoadjuvant therapy for gallbladder cancer: current status and challenge [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 110-114.
[5]	LUO Fangxiu, MA Qianchen, YUAN Fei. The fifth edition of WHO classification of digestive system tumors: update and progress on biliary system tumors [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 124-131.
[6]	WANG Yuanjiang, ZOU Hao. Clinical study on comprehensive treatment of gallbladder cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 171-176.
[7]	CHEN Xuanwu, YANG Chuanyu, JIANG Minjie, DU Weidong. Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 87-90.
[8]	WANG Kaiyu, WANG Liang, SHU Bin, ZHANG Yuewei, HUANG Xin, GE Xiaqing, XIAO Ming, ZHANG Qijia, YAN Zhe, SONG Yan, XIANG Canhong. Radical resection of hilar cholangiocarcinoma combined with left hepatectomy and resection of ventral segment of right anterior sector: one case report [J]. Journal of Surgery Concepts & Practice, 2021, 26(05): 441-444.
[9]	WU Wenta, LI Wei, CAO Yijun. Diagnosis and treatment of xanthogranulomatous cholecystitis [J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 271-274.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 107-110.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 115-119.
[12]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 120-123.
[13]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 124-129.
[14]	LIU Hongzhi, LIN Ziguo, HUANG Jianlong, ZHOU Weiping, CHENG Zhangjun, LOU Jianying, ZHENG Shuguo, BI Xinyu, WANG Jianming, GUO Wei, LI Fuyu, WANG Jian, ZHENG Yamin, LI Jingdong, CHENG Shi, LIU Jingfeng, ZENG Yongyi. Effect of surgical margin width on prognosis in patients with single intrahepatic cholangiocarcinoma from a multicenter study [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 130-137.
[15]	SI Anfeng, LEI Zhengqing, YANG Pinghua, JIANG Tao, WANG Xuan, CHENG Zhangjun. Effectiveness of postoperative transarterial chemoembolization for huge intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 138-143.